Profiel
Mr. Adam Townsend is a President, Chief Executive Officer & Director at Merida Biosciences, Inc. He is on the Board of Directors at Merida Biosciences, Inc. Mr. Townsend was previously employed as a Chief Operating Officer by Apellis Pharmaceuticals, Inc., a Senior Vice President-Corporate Development by Biogen, Inc., and a General Manager-UK, Ireland & Nordic Region by EUSA Pharma, Inc. He received his undergraduate degree from Royal Holloway University of London.
Actieve functies van Adam Townsend
| Bedrijven | Functie | Begin |
|---|
Eerdere bekende functies van Adam Townsend
| Bedrijven | Functie | Einde |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Operationeel Directeur | 21-02-2025 |
| BIOGEN INC. | Corporate Officer/Principal | 01-10-2018 |
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and researches pharmaceutical products | Corporate Officer/Principal | 01-03-2010 |
Opleiding van Adam Townsend
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and researches pharmaceutical products | Health Technology |
Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
Royal Holloway University of London
Royal Holloway University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















